| Literature DB >> 26627057 |
A J Melchiorri1, N Hibino2,3, C A Best2, T Yi2, Y U Lee2, C A Kraynak1, L K Kimerer1, A Krieger4, P Kim1, C K Breuer3, J P Fisher1.
Abstract
Congenital heart defect interventions may benefit from the fabrication of patient-specific vascular grafts because of the wide array of anatomies present in children with cardiovascular defects. 3D printing is used to establish a platform for the production of custom vascular grafts, which are biodegradable, mechanically compatible with vascular tissues, and support neotissue formation and growth.Entities:
Keywords: 3D printing; biodegradable grafts; biodegradable polyesters; biomaterials; poly(propylene fumarate)
Mesh:
Substances:
Year: 2015 PMID: 26627057 PMCID: PMC4749136 DOI: 10.1002/adhm.201500725
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933